1.福建中医药大学第一临床医学院,福建 福州 350122
2.福建中医药大学附属第二人民医院呼吸科,福建 福州 350003
3.福建省早期肺癌中西医结合诊疗临床医学研究中心,福建 福州 350003
程慧娟,第一作者,研究方向:呼吸系统疾病的中西医结合临床诊治,E-mail:huijuan0411@163.com
收稿:2026-04-07,
修回:2026-04-22,
录用:2026-06-05,
网络首发:2026-07-21,
纸质出版:2026-07-20
移动端阅览
程慧娟,卢峰.多组学在肺结节良恶性鉴别与风险分层中的研究进展[J].中山大学学报(医学科学版),2026,47(04):627-635.
CHENG Huijuan,LU Feng.Recent Advances in Multi-omics for Benign-malignant Differentiation and Risk Stratification of Pulmonary Nodules[J].Journal of Sun Yat-sen University(Medical Sciences),2026,47(04):627-635.
程慧娟,卢峰.多组学在肺结节良恶性鉴别与风险分层中的研究进展[J].中山大学学报(医学科学版),2026,47(04):627-635. DOI: 10.11714/jsysu.med.YX20260054.
CHENG Huijuan,LU Feng.Recent Advances in Multi-omics for Benign-malignant Differentiation and Risk Stratification of Pulmonary Nodules[J].Journal of Sun Yat-sen University(Medical Sciences),2026,47(04):627-635. DOI: 10.11714/jsysu.med.YX20260054.
肺结节良恶性鉴别与风险分层是肺癌筛查及临床管理中的关键问题。传统评估主要依赖影像学判断、动态随访和病理取证,但在小结节、磨玻璃结节及炎性病变等情境下仍存在局限。近年来,影像组学、基因组学、转录组学、蛋白质组学、代谢组学及微生物组学等技术不断发展,从影像表型、遗传变异、分子表达、功能状态、代谢重塑及宿主-微生物互作等不同层面,为肺结节精准评估提供了多层级生物学证据。相较于单一组学,多组学整合通过跨层级信息融合,可更全面地揭示肺结节的生物学异质性,进一步提高良恶性鉴别与风险分层效能,相关研究显示其AUC可由0.80~0.87提升至0.93。本文系统综述多组学在肺结节良恶性鉴别与风险分层中的研究进展,重点分析其在生物标志物筛选、风险评估及临床决策支持中的应用价值,并对当前标准化不足、外部验证有限及临床转化挑战进行总结,以期为肺结节精准管理研究提供参考。
Benign-malignant differentiation and risk stratification of pulmonary nodules are critical issues in lung cancer screening and clinical management. Conventional assessment mainly relies on imaging evaluation, dynamic follow-up, and pathological confirmation, but its diagnostic performance remains limited in clinical scenarios involving small nodules, ground-glass nodules, and inflammatory lesions. In recent years, advances in radiomics, genomics, transcriptomics, proteomics, metabolomics, and microbiomics have provided multi-level biological evidence for the precise evaluation of pulmonary nodules from the perspectives of imaging phenotype, genetic variation, molecular expression, functional status, metabolic reprogramming, and host-microbe interaction. Compared with single-omics approaches, multi-omics integration, through cross-level information fusion, enables a more comprehensive characterization of the biological heterogeneity of pulmonary nodules and further improves the performance of benign-malignant differentiation and risk stratification. Relevant studies showed that the area under the curve (AUC) increased from 0.80-0.87 to 0.93. This review systematically summarizes recent advances in multi-omics research for benign-malignant differentiation and risk stratification of pulmonary nodules, with a focus on their value in biomarker discovery, risk assessment, and clinical decision support. Current challenges, including lack of standardization, insufficient external validation, and barriers to clinical translation, are also discussed to provide references for future research on precision management of pulmonary nodules.
Siegel RL , Kratzer TB , Giaquinto AN , et al . Cancer statistics, 2025 [J]. CA Cancer J Clin , 2025 , 75 ( 1 ): 10 - 45 .
中华医学会肿瘤学分会 . 中华医学会肺癌临床诊疗指南(2025版) [J]. 中华肿瘤杂志 , 2025 , 47 ( 9 ): 769 - 810 .
Oncology Branch of Chinese Medical Association . Clinical practice guideline for lung cancer of Chinese Medical Association (2025 edition) [J]. Chin J Oncol , 2025 , 47 ( 9 ): 769 - 810 .
王亚婕 , 周宇涵 , 雷丽敏 , 等 . 超低剂量超高分辨率光子计数探测器CT评估肺结节图像质量和体积变异 [J]. 临床放射学杂志 , 2026 , 45 ( 3 ): 451 - 458 .
Wang YJ , Zhou YH , Lei LM , et al . Evaluation of image quality and volumetric variability of pulmonary nodules using ultra-low-dose ultra-high-resolution photon-counting detector CT [J]. J Clin Radiol , 2026 , 45 ( 3 ): 451 - 458 .
Guo LW , Lyu ZY , Liu Y , et al . The probability of lung cancer in patients with pulmonary nodules detected via low-dose computed tomography screening in China [J]. BMC Cancer , 2025 , 25 ( 1 ): 1058 .
Chen D , Yang L , Zhang W , et al . Prevalence and management of pulmonary nodules: a systematic review and meta-analysis [J]. J Thorac Dis , 2024 , 16 ( 7 ): 4619 - 4632 .
Prokop M , Schaefer-Prokop C , Jacobs C , et al . Aggressiveness-guided nodule management for lung cancer screening in Europe: justification for follow-up intervals and definition of growth [J]. Eur Radiol , 2026 , 36 ( 1 ): 122 - 134 .
Zhao M , Xue G , He B , et al . Integrated multiomics signatures to optimize the accurate diagnosis of lung cancer [J]. Nat Commun , 2025 , 16 ( 1 ): 84 .
Chen YC , Hsu CL , Wang HM , et al . Multiomics analysis reveals molecular changes during early progression of precancerous lesions to lung adenocarcinoma in never-smokers [J]. Cancer Res , 2025 , 85 ( 3 ): 602 - 617 .
Chen H , Kim AW , Hsin M , et al . The 2023 American Association for Thoracic Surgery (AATS) expert consensus document: management of subsolid lung nodules [J]. J Thorac Cardiovasc Surg , 2024 , 168 ( 3 ): 631 - 647.e11 .
Kapsoritakis N , Tsitoura F , Stathaki M , et al . Clinical impact of FDG PET/CT in pulmonary nodule characterization: current perspectives on dual-time-point imaging and semi-quantitative imaging metrics [J]. Cancers (Basel) , 2025 , 17 ( 20 ): 3353 .
周青青 , 徐海 , 吴婧 , 等 . MRI多序列成像鉴别肺良恶性实性结节的研究 [J]. 影像诊断与介入放射学 , 2024 , 33 ( 6 ): 395 - 402 .
Zhou QQ , Xu H , Wu J , et al . Differentiation of benign and malignant solid pulmonary nodules on multi-sequence MRI [J]. Diagn lmaging & lnterv Radiol , 2024 , 33 ( 6 ): 395 - 402 .
中国肺癌早诊早治专家组 , 中国西部肺癌研究协作中心 , 周清华 , 等 . 中国肺癌低剂量CT筛查指南(2025年版) [J]. 中国肺癌杂志 , 2025 , 28 ( 12 ): 887 - 895 .
Chinese Expert Group for Early Detection and Early Treatment of Lung Cancer , China Western Lung Cancer Research Collaborative Group , Zhou QH , et al . Guidelines for low-dose CT screening of lung cancer in China (2025 edition) [J]. Chin J Lung Cancer , 2025 , 28 ( 12 ): 887 - 895 .
Perez C , Weiser L , Yu W , et al . Leveraging technology to help the patient: combined robotic bronchoscopic biopsy with surgical resection during the same anesthetic event [J]. JTCVS Tech , 2025 , 33 : 230 - 237 .
周正 , 吴俊翰 , 卢国杰 , 等 . 肺结节管理中人工智能多维应用: 从早期检测到手术决策支持 [J]. 中国胸心血管外科临床杂志 , 2025 , 32 ( 12 ): 1786 - 1791 .
Zhou Z , Wu JH , Lu GJ , et al . Multidimensional application of artificial intelligence in pulmonary nodule management: from early detection to surgical decision support [J]. Chin J Clin Thorac Cardiovasc Surg , 2025 , 32 ( 12 ): 1786 - 1791 .
Sun Y , Ge X , Niu R , et al . PET/CT radiomics and deep learning in the diagnosis of benign and malignant pulmonary nodules: progress and challenges [J]. Front Oncol , 2024 , 14 : 1491762 .
薛文赫 , 陈楠 , 刘伦旭 . 基于CT影像预测肺结节生长规律的研究进展 [J]. 中国胸心血管外科临床杂志 , 2025 , 32 ( 5 ): 581 - 586 .
Xue WH , Chen N , Liu LX . Research progress in predicting growth patterns of pulmonary nodules based on CT imaging [J]. Chin J Clin Thorac Cardiovasc Surg , 2025 , 32 ( 5 ): 581 - 586 .
Ardila D , Kiraly AP , Bharadwaj S , et al . End-to-end lung cancer screening with three-dimensional deep learning on low-dose chest computed tomography [J]. Nat Med , 2019 , 25 ( 6 ): 954 - 961 .
Huang L , Lin W , Xie D , et al . Development and validation of a preoperative CT-based radiomic nomogram to predict pathology invasiveness in patients with a solitary pulmonary nodule: a machine learning approach, multicenter, diagnostic study [J]. Eur Radiol , 2022 , 32 ( 3 ): 1983 - 1996 .
张榕 , 蔡宏杰 , 梁演婷 , 等 . 可视化影像决策模型在评估肺结节浸润程度中的价值 [J]. 放射学实践 , 2024 , 39 ( 8 ): 1032 - 1039 .
Zhang R , Cai HJ , Liang YT , et al . Value of a visualized imaging decision model in assessing the degree of pulmonary nodule infiltration [J]. Radiol Pract , 2024 , 39 ( 8 ): 1032 - 1039 .
Wu L , Gao C , Xu M . Radiomics to predict invasiveness of lung adenocarcinoma in part-solid nodules [J]. Radiology , 2021 , 300 ( 3 ): E348 .
Hong J , Yang L , Huo J , et al . Predicting the invasiveness of pulmonary adenocarcinoma using intratumoral and peritumoral radiomics features [J]. Front Med (Lausanne) , 2025 , 12 : 1541682 .
常儒玺 , 罗量 , 王睿妍 , 等 . 倾向性得分匹配后18F-氟代脱氧葡萄糖PET/CT参数在鉴别肺结节良恶性效能中的研究 [J]. 实用放射学杂志 , 2025 , 41 ( 5 ): 762 - 766 .
Chang RX , Luo L , Wang RY , et al . Efficacy of 18F-fluorodeoxyglucose PET/CT parameters in differentiating benign and malignant pulmonary nodules after propensity score matching [J]. J Pract Radiol , 2025 , 41 ( 5 ): 762 - 766 .
郑志娟 , 李姝霖 , 马昆 , 等 . 深度学习重建算法对胸部CT图像质量及肺结节影像组学特征数据可重复性的影响 [J]. 中国医学影像技术 , 2025 , 41 ( 1 ): 79 - 83 .
Zheng ZJ , Li SL , Ma K , et al . Effect of a deep learning reconstruction algorithm on chest CT image quality and repeatability of radiomic features of pulmonary nodules [J]. Chin J Med Imaging Technol , 2025 , 41 ( 1 ): 79 - 83 .
Yang SX , Li M , Zhou LN , et al . Reproducibility of the CT radiomic features of pulmonary nodules: the effects of the CT reconstruction algorithm, radiation dose, and contrast agent [J]. Quant Imaging Med Surg , 2025 , 15 ( 3 ): 2309 - 2318 .
Du H , Shen J , Chen F , et al . Integrating CT-based radiomics and deep learning for invasive prediction of ground-glass nodules in lung adenocarcinoma: a multicohort study [J]. Insights Imaging , 2025 , 16 ( 1 ): 271 .
Haga Y , Sakamoto Y , Kajiya K , et al . Whole-genome sequencing reveals the molecular implications of the stepwise progression of lung adenocarcinoma [J]. Nat Commun , 2023 , 14 ( 1 ): 8375 .
Liang P , Peng M , Tao J , et al . Development of a genome atlas for discriminating benign, preinvasive, and invasive lung nodules [J]. MedComm (2020), 2024 , 5 ( 8 ): e644 .
Pathak GP , Shah R , Reiman T , et al . Identification of driver mutations and risk stratification in lung adenocarcinoma via liquid biopsy [J]. Cancers (Basel) , 2025 , 17 ( 8 ): 1340 .
Wang H , Huang H , Li F , et al . Risk-stratified classification of pulmonary nodule malignancy via a machine learning model integrating imaging and cell-free DNA: a model development and validation study (DECIPHER-NODL) [J]. Lancet Reg Health West Pac , 2025 , 64 : 101730 .
Liang W , Tao J , Cheng C , et al . A clinically effective model based on cell-free DNA methylation and low-dose CT for risk stratification of pulmonary nodules [J]. Cell Rep Med , 2024 , 5 ( 10 ): 101750 .
Chou TY , Dacic S , Wistuba I , et al . Differentiating separate primary lung adenocarcinomas from intrapulmonary metastases with emphasis on pathological and molecular considerations: recommendations from the International Association for the Study of Lung Cancer Pathology Committee [J]. J Thorac Oncol , 2025 , 20 ( 3 ): 311 - 330 .
Zhou D , Li YQ , Liu QX , et al . Integrated whole-exome and bulk transcriptome sequencing delineates the dynamic evolution from preneoplasia to invasive lung adenocarcinoma featured with ground-glass nodules [J]. Cancer Med , 2024 , 13 ( 11 ): e7383 .
Meng F , Sun Y , Li J , et al . Single-cell and spatial transcriptome landscapes reveal the spatial immune defense pattern shared by primary and brain metastatic lung adenocarcinoma [J]. J Thorac Dis , 2025 , 17 ( 11 ): 9927 - 9942 .
Antunes-Ferreira M , D'Ambrosi S , Arkani M , et al . Tumor-educated platelet blood tests for non-small cell lung cancer detection and management [J]. Sci Rep , 2023 , 13 ( 1 ): 9359 .
Ren YF , Ma Q , Zeng X , et al . Single-cell RNA sequencing reveals immune microenvironment niche transitions during the invasive and metastatic processes of ground-glass nodules and part-solid nodules in lung adenocarcinoma [J]. Mol Cancer , 2024 , 23 ( 1 ): 263 .
Yanagawa J , Tran LM , Salehi-Rad R , et al . Single-cell characterization of pulmonary nodules implicates suppression of immunosurveillance across early stages of lung adenocarcinoma [J]. Cancer Res , 2023 , 83 ( 19 ): 3305 - 3319 .
Xie L , Kong H , Yu J , et al . Spatial transcriptomics reveals heterogeneity of histological subtypes between lepidic and acinar lung adenocarcinoma [J]. Clin Transl Med , 2024 , 14 ( 2 ): e1573 .
Berndt JD , Duffy FJ , D'Ascenzo MD , et al . A multivariate cell-based liquid biopsy for lung nodule risk stratification: analytical validation and early clinical evaluation [J]. J Liquid Biopsy , 2025 , 9 : 100313 .
Takano Y , Suzuki J , Nomura K , et al . Spatially resolved gene expression profiling of tumor microenvironment reveals key steps of lung adenocarcinoma development [J]. Nat Commun , 2024 , 15 ( 1 ): 10637 .
Khodayari Moez E , Warkentin MT , Brhane Y , et al . Circulating proteome for pulmonary nodule malignancy [J]. J Natl Cancer Inst , 2023 , 115 ( 9 ): 1060 - 1070 .
赵慧莹 . 基于蛋白质组学的微小肺结节良恶性鉴别诊断血清标志物研究 [D]. 北京 : 北京协和医学院 , 2025 .
Zhao HY . Proteomics-based study on serum biomarkers for differential diagnosis of benign and malignant subcentimeter pulmonary nodules [D]. Beijing : Peking Union Medical College , 2025 .
Jia B , Wang T , Pan L , et al . An integrated proteomic classifier to distinguish benign from malignant pulmonary nodules [J]. Clin Proteom , 2025 , 22 ( 1 ): 11 .
Zhao R , Lu H , Yuan H , et al . Plasma proteomic profiles for early detection and risk stratification of non-small cell lung carcinoma: a prospective cohort study with 52,913 participants [J]. Int J Cancer , 2025 , 157 ( 8 ): 1577 - 1589 .
Sajic T , Vizovišek M , Arni S , et al . Depletion-dependent activity-based protein profiling using SWATH/DIA-MS detects serine hydrolase lipid remodeling in lung adenocarcinoma progression [J]. Nat Commun , 2025 , 16 ( 1 ): 4889 .
Ma S , Zhao N , Dong X , et al . Liquid biopsy-derived extracellular vesicle protein biomarkers for diagnosis and prognostic assessment of lung squamous cell carcinoma [J]. Cancer Cell Int , 2025 , 25 : 161 .
Wang Y , Xu M , Wei X , et al . Prospective proteomics for discovering biomarkers in lung adenocarcinoma: a literature review [J]. Transl Cancer Res , 2025 , 14 ( 9 ): 6102 - 6117 .
Wan Q , Zhang Z , Zhao M , et al . Efficient diagnosis of benign and malignant pulmonary nodules based on nano-zero-valent iron enhanced serum metabolic fingerprinting [J]. Chin Chem Lett , 2025 , 36 ( 10 ): 110794 .
Liu Z , Wang L , Gao S , et al . Plasma metabolites as biomarkers for screening and differential diagnosis of lung cancer [J]. J Cardiothorac Surg , 2025 , 20 ( 1 ): 456 .
Yao Y , Wang X , Guan J , et al . Metabolomic differentiation of benign vs malignant pulmonary nodules with high specificity via high-resolution mass spectrometry analysis of patient sera [J]. Nat Commun , 2023 , 14 ( 1 ): 2339 .
Peixoto BP , Clague RA , Reddy JP , et al . The emerging roles of metabolic reprogramming in non-small cell lung cancer progression [J]. Front Biosci (Landmark Ed) , 2025 , 30 ( 7 ): 31363 .
Liu Z , Wang L , Gao S , et al . Prediction and analysis of the tumor invasiveness of pulmonary ground-glass nodules based on metabolomics [J]. Clin Exp Med , 2024 , 25 ( 1 ): 22 .
Zhang J , Zhang Z , Liu Y , et al . Metabolic characteristics of benign and malignant pulmonary nodules and establishment of invasive lung adenocarcinoma model by high-resolution mass spectrometry [J]. BMC Cancer , 2025 , 25 ( 1 ): 844 .
Zwijsen K , Wener RRL , Heirwegh E , et al . Differentiating benign and malignant solitary pulmonary nodules through exhaled breath analysis [J]. ERJ Open Res , 2026 , 12 ( 1 ): 00827 - 2025 .
Su Z , Yu X , He Y , et al . Inconsistencies in predictive models based on exhaled volatile organic compounds for distinguishing between benign pulmonary nodules and lung cancer: a systematic review [J]. BMC Pulm Med , 2024 , 24 ( 1 ): 551 .
Zyla J , Marczyk M , Prazuch W , et al . Combining low-dose computer-tomography-based radiomics and serum metabolomics for diagnosis of malignant nodules in participants of lung cancer screening studies [J]. Biomolecules , 2023 , 14 ( 1 ): 44 .
Li R , Li J , Zhou X . Lung microbiome: new insights into the pathogenesis of respiratory diseases [J]. Signal Transduct Target Ther , 2024 , 9 ( 1 ): 19 .
Huang C , He J , Fu X , et al . Association of multi-site microbial features with malignancy risk in pulmonary ground-glass nodules and identification of predictive biomarkers: a prospective multicenter cohort study [J]. J Transl Med , 2026 , 24 : 528 .
Ma Q , Huang CX , He JW , et al . Oral microbiota as a biomarker for predicting the risk of malignancy in indeterminate pulmonary nodules: a prospective multicenter study [J]. Int J Surg , 2025 , 111 ( 2 ): 2055 - 2071 .
Yuan Q , Wang X , Li Z , et al . A preliminary study on microbiota characteristics of bronchoalveolar lavage fluid in patients with pulmonary nodules based on metagenomic next-generation sequencing [J]. Biomedicines , 2023 , 11 ( 2 ): 631 .
Yan J , Chen D , Ye Z , et al . Molecular mechanisms and therapeutic significance of tryptophan metabolism and signaling in cancer [J]. Mol Cancer , 2024 , 23 ( 1 ): 241 .
Li X , Shang S , Wu M , et al . Gut microbial metabolites in lung cancer development and immunotherapy: novel insights into gut-lung axis [J]. Cancer Lett , 2024 , 598 : 217096 .
Yang M , Yu H , Feng H , et al . Enhancing the differential diagnosis of small pulmonary nodules: a comprehensive model integrating plasma methylation, protein biomarkers, and LDCT imaging features [J]. J Transl Med , 2024 , 22 ( 1 ): 984 .
Wang K , Deng XF , Zheng Z , et al . Development and validation of a multimodal radiomics-serum biomarker model for diagnosing solid pulmonary nodules via machine learning [J]. J Thorac Dis , 2025 , 17 ( 11 ): 9721 - 9734 .
Zhu B , Chen P , Aminu M , et al . Spatial and multiomics analysis of human and mouse lung adenocarcinoma precursors reveals TIM-3 as a putative target for precancer interception [J]. Cancer Cell , 2025 , 43 ( 6 ): 1125 - 1140.e10 .
McGann KC , Khalil TA , Kammer MN , et al . Biomarkers for the diagnosis of indeterminate pulmonary nodules: are we there yet? [J]. J Thorac Dis , 2025 , 17 ( 8 ): 6265 - 6282 .
0
浏览量
6
下载量
0
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备11010802024621
